Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5CF8

CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE

Summary for 5CF8
Entry DOI10.2210/pdb5cf8/pdb
Related5CF4 5CF5 5CF6
DescriptorTyrosine-protein kinase JAK2, N,N-dicyclopropyl-4-[(1,5-dimethyl-1H-pyrazol-3-yl)amino]-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide (3 entities in total)
Functional Keywordskinase, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Cellular locationEndomembrane system ; Peripheral membrane protein : O60674
Total number of polymer chains2
Total formula weight72256.27
Authors
Sack, J.S. (deposition date: 2015-07-08, release date: 2015-08-26, Last modification date: 2024-10-30)
Primary citationWan, H.,Schroeder, G.M.,Hart, A.C.,Inghrim, J.,Grebinski, J.,Tokarski, J.S.,Lorenzi, M.V.,You, D.,Mcdevitt, T.,Penhallow, B.,Vuppugalla, R.,Zhang, Y.,Gu, X.,Iyer, R.,Lombardo, L.J.,Trainor, G.L.,Ruepp, S.,Lippy, J.,Blat, Y.,Sack, J.S.,Khan, J.A.,Stefanski, K.,Sleczka, B.,Mathur, A.,Sun, J.H.,Wong, M.K.,Wu, D.R.,Li, P.,Gupta, A.,Arunachalam, P.N.,Pragalathan, B.,Narayanan, S.,K C, N.,Kuppusamy, P.,Purandare, A.V.
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms.
Acs Med.Chem.Lett., 6:850-855, 2015
Cited by
PubMed Abstract: JAK2 kinase inhibitors are a promising new class of agents for the treatment of myeloproliferative neoplasms and have potential for the treatment of other diseases possessing a deregulated JAK2-STAT pathway. X-ray structure and ADME guided refinement of C-4 heterocycles to address metabolic liability present in dialkylthiazole 1 led to the discovery of a clinical candidate, BMS-911543 (11), with excellent kinome selectivity, in vivo PD activity, and safety profile.
PubMed: 26288683
DOI: 10.1021/acsmedchemlett.5b00226
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

246031

数据于2025-12-10公开中

PDB statisticsPDBj update infoContact PDBjnumon